These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 35884281)

  • 1. Dual-Mode Tumor Imaging Using Probes That Are Responsive to Hypoxia-Induced Pathological Conditions.
    Subasinghe SAAS; Pautler RG; Samee MAH; Yustein JT; Allen MJ
    Biosensors (Basel); 2022 Jun; 12(7):. PubMed ID: 35884281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging Agents in Targeting Tumor Hypoxia.
    Zeng Y; Ma J; Zhang S; Wu D
    Curr Med Chem; 2016; 23(17):1775-800. PubMed ID: 26997152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular imaging of hypoxia with radiolabelled agents.
    Mees G; Dierckx R; Vangestel C; Van de Wiele C
    Eur J Nucl Med Mol Imaging; 2009 Oct; 36(10):1674-86. PubMed ID: 19565239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging the Tumor Microenvironment.
    Abadjian MZ; Edwards WB; Anderson CJ
    Adv Exp Med Biol; 2017; 1036():229-257. PubMed ID: 29275475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-Responsive Luminescent CEST MRI Agent for
    Karan S; Cho MY; Lee H; Park HS; Han EH; Song Y; Lee Y; Kim M; Cho JH; Sessler JL; Hong KS
    J Med Chem; 2022 May; 65(10):7106-7117. PubMed ID: 35580357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 99mTc-Labeled Iron Oxide Nanoparticles for Dual-Contrast (T1/T2) Magnetic Resonance and Dual-Modality Imaging of Tumor Angiogenesis.
    Xue S; Zhang C; Yang Y; Zhang L; Cheng D; Zhang J; Shi H; Zhang Y
    J Biomed Nanotechnol; 2015 Jun; 11(6):1027-37. PubMed ID: 26353592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor hypoxia imaging.
    Sun X; Niu G; Chan N; Shen B; Chen X
    Mol Imaging Biol; 2011 Jun; 13(3):399-410. PubMed ID: 20838906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prospect of hypoxia imaging of nuclear medicine in tumors].
    Chen G; Wang RF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 38(3):335-inside back cover. PubMed ID: 16778985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular probes for the in vivo imaging of cancer.
    Alford R; Ogawa M; Choyke PL; Kobayashi H
    Mol Biosyst; 2009 Nov; 5(11):1279-91. PubMed ID: 19823742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncovalent Dual-Locked Near-Infrared Fluorescent Probe for Precise Imaging of Tumor via Hypoxia/Glutathione Activation.
    Zhao XB; Kang JY; Shi YP
    Anal Chem; 2022 May; 94(17):6574-6581. PubMed ID: 35437984
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Janasik D; Krawczyk T
    Chemistry; 2022 Jan; 28(5):e202102556. PubMed ID: 34705306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging hypoxia in tumours with advanced MRI.
    Price JM; Robinson SP; Koh DM
    Q J Nucl Med Mol Imaging; 2013 Sep; 57(3):257-70. PubMed ID: 24045622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Imaging of Pancreatic Cancer with Antibodies.
    England CG; Hernandez R; Eddine SB; Cai W
    Mol Pharm; 2016 Jan; 13(1):8-24. PubMed ID: 26620581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical Design and Synthesis of Functionalized Probes for Imaging and Treating Tumor Hypoxia.
    Liu JN; Bu W; Shi J
    Chem Rev; 2017 May; 117(9):6160-6224. PubMed ID: 28426202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional imaging of intratumoral hypoxia.
    Foo SS; Abbott DF; Lawrentschuk N; Scott AM
    Mol Imaging Biol; 2004; 6(5):291-305. PubMed ID: 15380739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-activated probe for NIR fluorescence and photoacoustic dual-mode tumor imaging.
    Li M; Li H; Wu Q; Niu N; Huang J; Zhang L; Li Y; Wang D; Tang BZ
    iScience; 2021 Mar; 24(3):102261. PubMed ID: 33763638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodal Functional Imaging for Cancer/Tumor Microenvironments Based on MRI, EPRI, and PET.
    Matsumoto KI; Mitchell JB; Krishna MC
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33799481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic In Vivo Visualization of Pituitary Adenomas: a Systematic Review of Imaging Modalities.
    Yao A; Balchandani P; Shrivastava RK
    World Neurosurg; 2017 Aug; 104():489-498. PubMed ID: 28461279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of Tumor Metabolism Using Positron Emission Tomography (PET).
    Apostolova I; Wedel F; Brenner W
    Recent Results Cancer Res; 2016; 207():177-205. PubMed ID: 27557539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.